Hpharma SRL
Hpharma reported total assets of 789,401 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Hpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +4 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 18,505 € | ||||
| Equity | 264,577 € | ||||
| Cash | 90,363 € | ||||
| EBITDA | 110,897 € | ||||
| Total assets | 789,401 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 13 Aug 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Hpharma's financial analysis
- Solvency33.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hpharma
Hpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0680.620.492
- VAT number
- BE0680620492
- Peppol
- Registered · 0208:0680620492 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Aug 2017
- Registered office
- 6220 Fleurus
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hpharma (SRL) has been based in Fleurus since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 18,505 € and equity of 264,577 €; its revenue is not published. Its solvency stands at 33.5%, below the median of its sector (41.5%).
Companies similar to Hpharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Corne Retail sale of pharmaceutical products Kortrijk · balance sheet 789,558 €
- Pharmacie Allart TH Retail sale of pharmaceutical products Charleroi · balance sheet 788,778 €
- Dr. Apr. D. Kieffer Retail sale of pharmaceutical products Hasselt · balance sheet 790,139 €
- Paal Farma Retail sale of pharmaceutical products Beringen · balance sheet 790,795 €
- WD-Farma Retail sale of pharmaceutical products Antwerp · balance sheet 787,913 €
- Gooreind Pharma Retail sale of pharmaceutical products Wuustwezel · balance sheet 791,241 €
- Cobra Apotheek Centrum Retail sale of pharmaceutical products Mol · balance sheet 791,276 €
- Sanimed Retail sale of pharmaceutical products Oudenburg · balance sheet 786,238 €
Frequently asked questions about Hpharma
What is the revenue of Hpharma?
Hpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0680620492 for Hpharma, if the company is VAT-registered. Its company number (CBE) is 0680.620.492.
Where is the registered office of Hpharma?
According to the CBE register, the registered office of Hpharma is in 6220 Fleurus.
What is the equity of Hpharma?
At the close of the 2025 financial year, the equity of Hpharma amounts to 264,577 €, a solvency of 33.5% of total assets.
Who manages Hpharma?
The register lists 2 active mandates at Hpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →